What's Behind Organogenesis' Recent Stock Plunge and Q1 2026 Revenue Drop

Related Articles

What's Behind zSpace's Recent Stock Plunge

2 months ago

What's Behind TruBridge's Recent Stock Plunge

4 months ago

What's Behind Zscaler's Recent Stock Plunge

5 months ago

What's Behind Centene's Recent Stock Plunge

4 months ago

Category

You may also like

Stock News•1 months ago

GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

GeneDx Holdings (WGS) shares fell 49% following a disconnect between the company's recent performance and its prior growth narrative. This sharp decline has triggered increased investor scrutiny regar...

WGS

Share

Stock News•2 months ago

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

ADMA Biologics shares fell 22% over the past month after the company lowered its 2026 guidance. Management cited increased pricing pressure, rising competition, and elevated IG channel inventories as ...

ADMA

Share

Stock News•2 months ago

Why Is Upstart Stock Crashing, and is it a Buying Opportunity?

Upstart shares fell following the company's latest quarterly earnings report, as investors reacted negatively to the disclosed financial results. The market sell-off reflects broader concerns regardin...

UPST

Share

Stock News•2 months ago

Organogenesis Q1 Earnings Call Highlights

Organogenesis (ORGO) reported a sharp year-over-year revenue decline in Q1 2026. The downturn follows significant disruption in the skin substitute market caused by recent Medicare policy changes and ...

ORGO

Share